Hepatitis C Viral Kinetics The Past, Present, and Future

被引:21
作者
Chatterjee, Anushree [1 ,2 ]
Smith, Patrick F. [3 ]
Perelson, Alan S. [1 ]
机构
[1] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM 87545 USA
[2] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA
[3] Roche, Clin Pharmacol Pharma Res & Early Dev, Nutley, NJ USA
关键词
Mathematical modeling; Viral kinetics; Direct-acting antiviral agents; Protease inhibitors; Hepatitis C virus; DYNAMICS IN-VIVO; POLYMERASE INHIBITOR; ANTIVIRAL ACTIVITY; PROTEASE INHIBITORS; VIRUS-REPLICATION; TREATMENT-NAIVE; NONNUCLEOSIDE POLYMERASE; RESISTANCE MUTATIONS; ALPHA-INTERFERON; WILD-TYPE;
D O I
10.1016/j.cld.2012.09.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mathematical modeling of hepatitis C viral kinetics has been an important tool in understanding hepatitis C virus (HCV) infection dynamics and in estimating crucial in vivo parameters characterizing the effectiveness of HCV therapy. Because of the introduction of direct-acting antiviral agents, there is a need to extend previous models so as to understand, characterize, and compare various new HCV treatment regimens. Here we review recent modeling efforts in this direction.
引用
收藏
页码:13 / +
页数:15
相关论文
共 70 条
[1]   Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C [J].
Abdelmalek, MF ;
Firpi, RJ ;
Soldevila-Pico, C ;
Reed, AI ;
Hemming, AW ;
Liu, C ;
Crawford, JM ;
Davis, GL ;
Nelson, DR .
LIVER TRANSPLANTATION, 2004, 10 (02) :199-207
[2]   A Multi-Variant, Viral Dynamic Model of Genotype 1 HCV to Assess the in vivo Evolution of Protease-Inhibitor Resistant Variants [J].
Adiwijaya, Bambang S. ;
Herrmann, Eva ;
Hare, Brian ;
Kieffer, Tara ;
Lin, Chao ;
Kwong, Ann D. ;
Garg, Varun ;
Randle, John C. R. ;
Sarrazin, Christoph ;
Zeuzem, Stefan ;
Caron, Paul R. .
PLOS COMPUTATIONAL BIOLOGY, 2010, 6 (04)
[3]  
Adiwijaya BS, 2009, ANTIVIR THER, V14, P591
[4]   Silibinin and Related Compounds Are Direct Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase [J].
Ahmed-Belkacem, Abdelhakim ;
Ahnou, Nazim ;
Barbotte, Laetitia ;
Wychowski, Czeslaw ;
Pallier, Coralie ;
Brillet, Rozenn ;
Pohl, Ralf-Torsten ;
Pawlotsky, Jean-Michel .
GASTROENTEROLOGY, 2010, 138 (03) :1112-1122
[5]   Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3•4A protease inhibitors in treatment-naive subjects [J].
Bartels, Doug J. ;
Zhou, Yi ;
Zhang, Eileen Z. ;
Marcial, Michelle ;
Byrn, Randal A. ;
Pfeiffer, Thomas ;
Tigges, Ann M. ;
Adiwijaya, Bambang S. ;
Lin, Chao ;
Kwong, Ann D. ;
Kieffer, Tara L. .
JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (06) :800-807
[6]   Pharmacokinetic-Pharmacodynamic Modeling of Alpha Interferon Response Induced by a Toll-Like 7 Receptor Agonist in Mice [J].
Benson, Neil ;
de Jongh, Joost ;
Duckworth, Jonathan D. ;
Jones, Hannah M. ;
Pertinez, Henry E. ;
Rawal, Jaiessh K. ;
van Steeg, Tamara J. ;
Van der Graaf, Piet H. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (03) :1179-1185
[7]   Second-wave Protease Inhibitors: Choosing an Heir [J].
Ciesek, Sandra ;
von Hahn, Thomas ;
Manns, Michael P. .
CLINICS IN LIVER DISEASE, 2011, 15 (03) :597-+
[8]   DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A [J].
Coelmont, Lotte ;
Hanoulle, Xavier ;
Chatterji, Udayan ;
Berger, Carola ;
Snoeck, Joke ;
Bobardt, Michael ;
Lim, Precious ;
Vliegen, Inge ;
Paeshuyse, Jan ;
Vuagniaux, Gregoire ;
Vandamme, Anne-Mieke ;
Bartenschlager, Ralf ;
Gallay, Philippe ;
Lippens, Guy ;
Neyts, Johan .
PLOS ONE, 2010, 5 (10)
[9]   Modeling hepatitis C virus dynamics: Liver regeneration and critical drug efficacy [J].
Dahari, Harel ;
Lo, Arthur ;
Ribeiro, Ruy M. ;
Perelson, Alan S. .
JOURNAL OF THEORETICAL BIOLOGY, 2007, 247 (02) :371-381
[10]   Mathematical modeling of subgenomic hepatitis C virus replication in Huh-7 cells [J].
Dahari, Harel ;
Ribeiro, Ruy M. ;
Rice, Charles M. ;
Perelson, Alan S. .
JOURNAL OF VIROLOGY, 2007, 81 (02) :750-760